Lorazepam Tablets Recalled Due to Sub-Potency and Failed Stability Testing
The Harvard Drug Group is recalling Lorazepam Tablets USP 0.5mg due to sub-potency and failed stability test results. Approximately 82,281 cartons are affected nationwide and in Puerto Rico.
- Product
- LORAZEPAM — LORAZEPAM (LORAZEPAM)
- Category
- Drug
- Distribution
- Distributed nationwide